Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Telemedicine shows significant potential in ID, other specialty care
• Experts warn that hasty treatment designs could harm Ebola patients
• 10 economic consequences of the Ebola crisis
• CDC outlines Ebola risk levels, potential public health actions
• Ebola in US triggers travel screening, advanced protocols for HCWs
• Health experts argue for swifter trial designs of experimental Ebola treatment
• The Ebola epidemic: A costly and preventable global health security and humanitarian crisis James M. Hughes, MD
• It’s not Ebola, but it’s also out of control Thomas M Yuill, PhD; Donald Kaye, MD, MACP
• FDA approves first Neisseria meningitidis vaccine
• Rapid diagnostic tests performed poorly in detecting chikungunya virus
• CDI incidence nearly doubled from 2001 to 2010
• Patient costs greater at hospital-owned physician groups
• Typhoid surveillance, vaccination lacking in endemic areas
• Beta-lactam monotherapy failed to show noninferiority for CAP
• Flu vaccine may be most effective in patients not vaccinated in past 5 years
• Global polio eradication on horizon, international efforts needed
• HCV core-antigen test cheaper, quicker than RNA PCR
• HCW exposure to rabies required conservative approach for PEP
• HEV antibody prevalence decreased in Germany across 15 years
• HIV testing increased among MSM
• Immunocompromised patients with HSV meningitis may benefit from antiviral therapy
• Intervention may not reduce risky behaviors among those with HIV
• Lab test adapted to identify new Lyme treatments
• Low levels of influenza documented in US through summer
• Low vaccination rates, comorbidities risk factors for pH1N1-related pneumonia
• Networking strategy may decrease HCV prevalence among injection drug users
• No association between HCV, diabetes in US population
• Novel poxvirus caused cutaneous infections in patients exposed to farm animals
• Oral, frozen FMT capsules treated diarrhea linked to recurrent CDI
• Recorded outbreaks, unique diseases increased since 1980
• Spontaneous HBeAg seroclearance increased chances for HBsAg seroclearance
• SVR after therapy reduced inflammation, fibrosis in HCV patients
• Younger age, higher CD4 count at ART initiation increased recovery odds
• No source of Herbaspirillum spp. identified in cluster of patients
• Current tobacco use associated with oral HPV-16 infection
• NDM-producing E. coli outbreak linked to duodenoscopes
• ART beneficial for MSM with HIV reporting stimulant use
• Tropical diseases: What you should know
• Ceftolozane/tazobactam shows promise against gram-negative infections
• Novel program decreased MRSA infections by 65% in long-term care
• Two-thirds of eligible hospital patients refused flu vaccine
• Main source of S. aureus differed for community- and hospital-acquired infections
• Antibody testing in STD clinic identified high prevalence of HCV
• Efficacy similar between two single-tablet ART regimens in females
• Aerosolized A. baumannii more frequent among rectally colonized patients
• Athletes in contact sports more likely to carry MRSA
• C. difficile infections correlated with surgical site infections
• Decreased hemoglobin levels did not impact SVR rate in patients treated for HCV genotype 1
• Direct-acting antiviral therapy led to high SVR rates in patients with HCV genotype 1b
• EMS providers reported inconsistent sanitation practices, MDR awareness
• Fluoroquinolones could increase risk for MDR gram-negative bacilli colonization
• Gender, age variations observed in HIV cascade of care
• Immunization rates low among kidney transplant candidates
• No difference in clinical outcomes between NNRTI- and boosted PI-based ART
• Risk scores, black race linked to missing visits with HIV providers
• SECURE: Isavuconazole comparable to voriconazole in invasive mold disease
• Social networking identified more HIV infections than self-referral
• SSI rates higher among lower volume hospitals
• Norovirus found in 4% of gastroenteritis patients at VA hospitals
• New developments in vaccination for patients aged 65 years and older Jeff Brock, PharmD, MBA, BCIDP; Gregory Tallman, PharmD